福瑞達(600223.SH):公司旗下焦點福瑞達是全球領先的透明質酸原料生產基地之一
格隆匯8月7日丨福瑞達(600223.SH)近期在接待機構投資者調研時表示,原料及衍生產品、添加劑方面,公司旗下焦點福瑞達是全球領先的透明質酸原料生產基地之一,集透明質酸研發、生產、銷售為一體,在透明質酸行業產量及銷量均名列前茅。現擁有透明質酸原材料420噸/年的產能,目前生產食品級和化粧品級透明質酸,60%以上出口,外貿出口地區主要為東亞、北美、歐盟等。公司旗下福瑞達生物科技主要開展生物防腐劑和化粧品原料的研發、生產和銷售。食品添加劑方面,主要產品有納他黴素、乳酸鏈球菌素和復配食品防腐劑等,其中納他黴素市場佔有率在40%以上;化粧品功效原料方面,主要產品有聚穀氨酸、依克多因、積雪草提取物等。
另外,在功能性食品方面,一是圍繞“中藥+”方向推出了骨科補鈣等相關的成分類產品,二是圍繞“玻尿酸+”方向重點推送伽美博士、Boyo、玻小酸等相關品牌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.